Skip to main content
Top
Published in: Health Research Policy and Systems 1/2018

Open Access 01-12-2018 | Letter to the Editor

The Swedish Medical Products Agency’s rules of procedure

Author: Catarina Andersson Forsman

Published in: Health Research Policy and Systems | Issue 1/2018

Login to get access

Excerpt

The Swedish Medical Products Agency (MPA) is the Swedish national authority responsible for regulation and surveillance of the development, manufacturing and marketing of medicinal products. Relenza, a neuraminidase inhibitor used in the treatment of influenza, has been evaluated by both the Swedish MPA and the United States Food and Drug Administration. …
Metadata
Title
The Swedish Medical Products Agency’s rules of procedure
Author
Catarina Andersson Forsman
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Health Research Policy and Systems / Issue 1/2018
Electronic ISSN: 1478-4505
DOI
https://doi.org/10.1186/s12961-018-0372-3

Other articles of this Issue 1/2018

Health Research Policy and Systems 1/2018 Go to the issue